DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein

 [1];  [1];  [1];  [1];  [1];  [1];  [1]; ORCiD logo [1]
  1. Department of Psychiatry &, Biobehavioral Sciences, David Geffen School of Medicine at UCLA UCLA Los Angeles California
Publication Date:
Sponsoring Org.:
OSTI Identifier:
Grant/Contract Number:  
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Journal of Neuroscience Research
Additional Journal Information:
Journal Name: Journal of Neuroscience Research; Journal ID: ISSN 0360-4012
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United States

Citation Formats

Sarafian, Theodore A., Yacoub, Amneh, Kunz, Anastasia, Aranki, Burkan, Serobyan, Grigor, Cohn, Whitaker, Whitelegge, Julian P., and Watson, Joseph B. Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein. United States: N. p., 2019. Web. doi:10.1002/jnr.24513.
Sarafian, Theodore A., Yacoub, Amneh, Kunz, Anastasia, Aranki, Burkan, Serobyan, Grigor, Cohn, Whitaker, Whitelegge, Julian P., & Watson, Joseph B. Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein. United States.
Sarafian, Theodore A., Yacoub, Amneh, Kunz, Anastasia, Aranki, Burkan, Serobyan, Grigor, Cohn, Whitaker, Whitelegge, Julian P., and Watson, Joseph B. Fri . "Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein". United States.
title = {Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein},
author = {Sarafian, Theodore A. and Yacoub, Amneh and Kunz, Anastasia and Aranki, Burkan and Serobyan, Grigor and Cohn, Whitaker and Whitelegge, Julian P. and Watson, Joseph B.},
abstractNote = {},
doi = {10.1002/jnr.24513},
journal = {Journal of Neuroscience Research},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {8}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 1 work
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species
journal, March 2017

A Water Soluble CoQ10 Formulation Improves Intracellular Distribution and Promotes Mitochondrial Respiration in Cultured Cells
journal, March 2012

Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury
journal, June 2015

  • Liu, Yang; Zhang, Ren-Yu; Zhao, Jun
  • International Journal of Molecular Sciences, Vol. 16, Issue 12
  • DOI: 10.3390/ijms160714395

Mitochondrial dysfunction in Parkinson's disease
journal, August 2016

  • Bose, Anindita; Beal, M. Flint
  • Journal of Neurochemistry, Vol. 139
  • DOI: 10.1111/jnc.13731

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
journal, August 2017

V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis
journal, January 1999

  • Lemasters, John J.
  • American Journal of Physiology-Gastrointestinal and Liver Physiology, Vol. 276, Issue 1
  • DOI: 10.1152/ajpgi.1999.276.1.G1

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
journal, December 2012

  • Fitzmaurice, A. G.; Rhodes, S. L.; Lulla, A.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 2
  • DOI: 10.1073/pnas.1220399110

Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α-synuclein: Fibrillated α-Syn Enhances Synaptic Glutamate
journal, January 2017

  • Sarafian, Theodore A.; Littlejohn, Kaitlyn; Yuan, Sarah
  • Journal of Neuroscience Research, Vol. 95, Issue 9
  • DOI: 10.1002/jnr.24024

Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines
journal, May 2015

The genetics and neuropathology of Parkinson’s disease
journal, July 2012

S-methyl N-butylthiocarbamate sulfoxide
journal, November 1999

High Stability and Cooperative Unfolding of α-Synuclein Oligomers
journal, September 2014

  • Paslawski, Wojciech; Andreasen, Maria; Nielsen, Søren Bang
  • Biochemistry, Vol. 53, Issue 39
  • DOI: 10.1021/bi5007833

Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human α-Synuclein
journal, May 2013

Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
journal, February 2015

Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity
journal, March 2007

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
journal, March 2015

Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria
journal, April 2001

Cytotoxic and genotoxic potential of dopamine
journal, March 1999

Methionine oxidation stabilizes non-toxic oligomers of α-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions
journal, March 2010

  • Zhou, Wenbo; Long, Chunmei; Reaney, Stephen H.
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1802, Issue 3
  • DOI: 10.1016/j.bbadis.2009.12.004

Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
journal, February 2008

  • Devi, Latha; Raghavendran, Vijayendran; Prabhu, Badanavalu M.
  • Journal of Biological Chemistry, Vol. 283, Issue 14
  • DOI: 10.1074/jbc.M710012200

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
journal, June 2015

  • Peelaerts, W.; Bousset, L.; Van der Perren, A.
  • Nature, Vol. 522, Issue 7556
  • DOI: 10.1038/nature14547

Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential
journal, December 2015

  • Hong, Minho; Song, Ki Duk; Lee, Hak-Kyo
  • In Vitro Cellular & Developmental Biology - Animal, Vol. 52, Issue 3
  • DOI: 10.1007/s11626-015-9979-7

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
journal, January 2018

Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein
journal, October 2014

  • Subramaniam, Sudhakar Raja; Vergnes, Laurent; Franich, Nicholas R.
  • Neurobiology of Disease, Vol. 70
  • DOI: 10.1016/j.nbd.2014.06.017

Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
journal, May 2016

  • Werner-Allen, Jon W.; DuMond, Jenna F.; Levine, Rodney L.
  • Angewandte Chemie International Edition, Vol. 55, Issue 26
  • DOI: 10.1002/anie.201600277

Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo
journal, August 2008

Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein
journal, October 2018

  • Carmo-Gonçalves, Phelippe; do Nascimento, Lucas Alex; Cortines, Juliana R.
  • Biochemical and Biophysical Research Communications, Vol. 505, Issue 1
  • DOI: 10.1016/j.bbrc.2018.09.111

Parkinson's Disease
journal, September 2003

Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease
journal, November 2017

Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations
journal, April 2005

  • Norris, Erin H.; Giasson, Benoit I.; Hodara, Roberto
  • Journal of Biological Chemistry, Vol. 280, Issue 22
  • DOI: 10.1074/jbc.M412621200

To mdivi-1 or not to mdivi-1: Is that the question?: mdivi-1 as a Fission Inhibitor
journal, August 2017

  • Smith, George; Gallo, Gianluca
  • Developmental Neurobiology, Vol. 77, Issue 11
  • DOI: 10.1002/dneu.22519

Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane
journal, February 2015

  • Pacheco, Carla R.; Morales, Camila N.; Ramírez, Alejandra E.
  • Journal of Neurochemistry, Vol. 132, Issue 6
  • DOI: 10.1111/jnc.13060

Mitochondrial association of alpha-synuclein causes oxidative stress
journal, February 2008

  • Parihar, M. S.; Parihar, A.; Fujita, M.
  • Cellular and Molecular Life Sciences, Vol. 65, Issue 7-8
  • DOI: 10.1007/s00018-008-7589-1

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
journal, January 2017

  • Plotegher, N.; Berti, G.; Ferrari, E.
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep40699

In vivo demonstration that  -synuclein oligomers are toxic
journal, February 2011

  • Winner, B.; Jappelli, R.; Maji, S. K.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 10
  • DOI: 10.1073/pnas.1100976108

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
journal, June 2016

Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
journal, July 2009

  • Rees, Jennifer N.; Florang, Virginia R.; Eckert, Laurie L.
  • Chemical Research in Toxicology, Vol. 22, Issue 7
  • DOI: 10.1021/tx9000557

The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes
journal, December 2013

Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity
journal, December 2014

  • Luth, Eric S.; Bartels, Tim; Dettmer, Ulf
  • Biochemistry, Vol. 54, Issue 2
  • DOI: 10.1021/bi501188a

Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease
journal, July 2014

  • Casida, John E.; Ford, Breanna; Jinsmaa, Yunden
  • Chemical Research in Toxicology, Vol. 27, Issue 8
  • DOI: 10.1021/tx5002223

α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease
journal, June 2015

  • Rostovtseva, Tatiana K.; Gurnev, Philip A.; Protchenko, Olga
  • Journal of Biological Chemistry, Vol. 290, Issue 30
  • DOI: 10.1074/jbc.M115.641746

New insights into the complex role of mitochondria in Parkinson’s disease
journal, June 2019

Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
journal, July 2015

  • Mahul-Mellier, A-L; Vercruysse, F.; Maco, B.
  • Cell Death & Differentiation, Vol. 22, Issue 12
  • DOI: 10.1038/cdd.2015.79

A new method for purification of recombinant human α-synuclein in Escherichia coli
journal, July 2005

  • Huang, Chunjuan; Ren, Guoping; Zhou, Hui
  • Protein Expression and Purification, Vol. 42, Issue 1
  • DOI: 10.1016/j.pep.2005.02.014

Products of Cu( ii )-catalyzed oxidation of α-synuclein fragments containing M 1 -D 2 and H 50 residues in the presence of hydrogen peroxide
journal, January 2008

  • Kowalik-Jankowska, Teresa; Rajewska, Anna; Jankowska, Elżbieta
  • Dalton Trans., Issue 6
  • DOI: 10.1039/B714440G

Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I
journal, May 2004

  • Brunmair, Barbara; Lest, Andrea; Staniek, Katrin
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 311, Issue 1
  • DOI: 10.1124/jpet.104.068312

High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria
journal, July 2011

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
journal, June 2018

  • Ludtmann, Marthe H. R.; Angelova, Plamena R.; Horrocks, Mathew H.
  • Nature Communications, Vol. 9, Issue 1
  • DOI: 10.1038/s41467-018-04422-2

Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
journal, March 2015

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
journal, July 2013

  • Goldstein, David S.; Sullivan, Patti; Holmes, Courtney
  • Journal of Neurochemistry, Vol. 126, Issue 5
  • DOI: 10.1111/jnc.12345

Methionine oxidation, α-synuclein and Parkinson's disease
journal, January 2005

  • Glaser, Charles B.; Yamin, Ghiam; Uversky, Vladimir N.
  • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1703, Issue 2
  • DOI: 10.1016/j.bbapap.2004.10.008

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
journal, March 2018

  • Post, Michael R.; Lieberman, Ori J.; Mosharov, Eugene V.
  • Frontiers in Neuroscience, Vol. 12
  • DOI: 10.3389/fnins.2018.00161

Neuropathology of Parkinsonʼs Disease
journal, January 1996

Catechols in post-mortem brain of patients with Parkinson disease: Brain catechols in Parkinson disease
journal, November 2010

3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesis
journal, November 2003

Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein
journal, March 2009

Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca 2+ -induced Mitochondrial Dysfunction
journal, June 2014

  • Luth, Eric S.; Stavrovskaya, Irina G.; Bartels, Tim
  • Journal of Biological Chemistry, Vol. 289, Issue 31
  • DOI: 10.1074/jbc.M113.545749

Function of the asparagine 74 residue of the inhibitory γ-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo
journal, October 2011

Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
journal, February 2018

Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
journal, October 2007

  • Burke, William J.; Kumar, Vijaya B.; Pandey, Neeraj
  • Acta Neuropathologica, Vol. 115, Issue 2
  • DOI: 10.1007/s00401-007-0303-9

Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
journal, March 2010

  • Villalba, Jose M.; Parrado, Cristina; Santos-Gonzalez, Monica
  • Expert Opinion on Investigational Drugs, Vol. 19, Issue 4
  • DOI: 10.1517/13543781003727495

C-Terminal Turn Stability Determines Assembly Differences between Aβ40 and Aβ42
journal, January 2013

  • Roychaudhuri, Robin; Yang, Mingfeng; Deshpande, Atul
  • Journal of Molecular Biology, Vol. 425, Issue 2
  • DOI: 10.1016/j.jmb.2012.11.006

Coenzyme Q<sub>10</sub> Therapy
journal, January 2014

  • Garrido-Maraver, Juan; Cordero, Mario D.; Oropesa-Ávila, Manuel
  • Molecular Syndromology, Vol. 5, Issue 3-4
  • DOI: 10.1159/000360101

The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson’s disease
journal, December 2016

  • Al-Hilaly, Youssra K.; Biasetti, Luca; Blakeman, Ben J. F.
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep39171

ANS Binding Reveals Common Features of Cytotoxic Amyloid Species
journal, June 2010

  • Bolognesi, Benedetta; Kumita, Janet R.; Barros, Teresa P.
  • ACS Chemical Biology, Vol. 5, Issue 8
  • DOI: 10.1021/cb1001203

Assessing mitochondrial dysfunction in cells
journal, March 2011

  • Brand, Martin D.; Nicholls, David G.
  • Biochemical Journal, Vol. 435, Issue 2
  • DOI: 10.1042/BJ20110162

Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
journal, November 2013

  • Camilleri, Angelique; Zarb, Claire; Caruana, Mario
  • Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1828, Issue 11
  • DOI: 10.1016/j.bbamem.2013.06.026

Cytosolic Catechols Inhibit  -Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
journal, September 2006

Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
journal, December 2018

The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
journal, December 2010

Metal-Catalyzed Oxidation of α-Synuclein in the Presence of Copper(II) and Hydrogen Peroxide
journal, June 2000

  • Paik, Seung R.; Shin, Hyun-Ju; Lee, Ju-Hyun
  • Archives of Biochemistry and Biophysics, Vol. 378, Issue 2
  • DOI: 10.1006/abbi.2000.1822

3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson’s disease pathogenesis
journal, September 2001

Mdivi-1 Protects Adult Rat Hippocampal Neural Stem Cells against Palmitate-Induced Oxidative Stress and Apoptosis
journal, September 2017

  • Kim, Sehee; Kim, Chanyang; Park, Seungjoon
  • International Journal of Molecular Sciences, Vol. 18, Issue 9
  • DOI: 10.3390/ijms18091947

Understanding Parkinson's Disease
journal, January 1997

Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity
journal, September 2018

  • Manczak, Maria; Kandimalla, Ramesh; Yin, Xiangling
  • Human Molecular Genetics, Vol. 28, Issue 2
  • DOI: 10.1093/hmg/ddy335

Superoxide is the critical driver of DOPAL autoxidation, lysyl adduct formation, and crosslinking of α-synuclein
journal, May 2017

  • Werner-Allen, Jon W.; Levine, Rodney L.; Bax, Ad
  • Biochemical and Biophysical Research Communications, Vol. 487, Issue 2
  • DOI: 10.1016/j.bbrc.2017.04.050

Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho -Quinone
journal, June 2011

  • Anderson, David G.; Mariappan, S. V. Santhana; Buettner, Garry R.
  • Journal of Biological Chemistry, Vol. 286, Issue 30
  • DOI: 10.1074/jbc.M111.249532

Current perspective of mitochondrial biology in Parkinson's disease
journal, July 2018

Mfn2 deletion in brown adipose tissue protects from insulin resistance and impairs thermogenesis
journal, May 2017

Mitochondrial Complex I Deficiency in Parkinson's Disease
journal, March 1990

The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration
journal, January 2019

  • Mor, Danielle E.; Daniels, Malcolm J.; Ischiropoulos, Harry
  • Movement Disorders, Vol. 34, Issue 2
  • DOI: 10.1002/mds.27607

Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
journal, September 2015

  • Follmer, Cristian; Coelho-Cerqueira, Eduardo; Yatabe-Franco, Danilo Y.
  • Journal of Biological Chemistry, Vol. 290, Issue 46
  • DOI: 10.1074/jbc.M115.686584

Ginsenosides Rd and Re co-treatments improve rotenone-induced oxidative stress and mitochondrial impairment in SH-SY5Y neuroblastoma cells
journal, November 2017

  • González-Burgos, E.; Fernández-Moriano, Carlos; Lozano, R.
  • Food and Chemical Toxicology, Vol. 109
  • DOI: 10.1016/j.fct.2017.08.013

Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
journal, July 2014

  • Coelho-Cerqueira, Eduardo; Pinheiro, Anderson S.; Follmer, Cristian
  • Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 14
  • DOI: 10.1016/j.bmcl.2014.04.072